SWAV Stock Recent News
SWAV LATEST HEADLINES
Johnson & Johnson JNJ, -1.14% has agreed to acquire Shockwave Medical Inc. SWAV, -0.23% in an all-cash deal with an enterprise value of about $13 billion, the companies said Friday. J&J will pay $335 a share in cash, equal to a 4.7% premium over Shockwave's closing price Thursday at $319.99.
Johnson & Johnson will buy medical device maker Shockwave Medical for about $12.5 billion, the companies said on Friday, helping the healthcare conglomerate boost its portfolio of medical devices.
ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies.
A report surfaced that Johnson & Johnson was in talks to acquire Shockwave, though neither company has confirmed the rumors. An analyst initiated coverage on the stock.
Shockwave Medical's (SWAV) shares gain as rumors about its potential acquisition by an industry giant get media attention.
Shockwave Medical shares are trading more than 3% higher in Wednesday's session, having soared more than 10% since it was announced Johnson & Johnson (NYSE:JNJ) was considering buying it. The maker of medical devices to treat heart diseases was reported to be an acquisition target for the healthcare giant on Tuesday by the Wall Street Journal.
Shares of medical-device maker Shockwave Medical Inc. rose Tuesday following a report that Johnson & Johnson was in talks to acquire the company.
Johnson & Johnson is in talks to buy medical device maker Shockwave Medical , the Wall Street Journal reported on Tuesday.
ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies.
Does Shockwave Medical (SWAV) have what it takes to be a top stock pick for momentum investors? Let's find out.